SNIPR receives funding for the development of CRISPR-medicines to improve Environmental Enteric Dysfunction (EED) in pregnant women
SNIPR receives funding from the Bill & Melinda Gates Foundation to accelerate the development of SNIPR's microbial gene therapy platform to improve EED in pregnant women from low- and middle-income countries (LMICs).